Endovia Health Sciences Debt-to-EBITDA Ratio Growth & History (EDVA)
Endovia Health Sciences's debt-to-ebitda ratio was 0.17 for fiscal 2018.
View full Endovia Health Sciences company overviewEndovia Health Sciences annual debt-to-ebitda ratio history
| Fiscal year | Period ended | Debt-to-EBITDA ratio | Change | Growth |
|---|---|---|---|---|
| 2018 | 2018-12-31 | 0.17 | — | — |
| 2016 | 2016-12-31 | 8.19 | 7.59 | +1284.43% |
| 2015 | 2015-12-31 | 0.59 | −166.04 | −99.65% |
| 2014 | 2014-12-31 | 166.63 | 158.20 | +1877.25% |
| 2013 | 2013-12-31 | 8.43 | — | — |
Endovia Health Sciences quarterly debt-to-ebitda ratio
| Fiscal quarter | Period ended | Debt-to-EBITDA ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2018 | 2018-12-31 | 0.17 | — | — |
| Q3 2018 | 2018-09-30 | 0.67 | — | — |
| Q2 2018 | 2018-06-30 | 0.40 | — | — |
| Q4 2016 | 2016-12-31 | 8.19 | 7.59 | +1284.43% |
| Q3 2016 | 2016-09-30 | 0.41 | — | — |
| Q2 2016 | 2016-06-30 | 0.32 | — | — |
| Q1 2016 | 2016-03-31 | 0.43 | — | — |
| Q4 2015 | 2015-12-31 | 0.59 | −166.04 | −99.65% |
| Q4 2014 | 2014-12-31 | 166.63 | — | — |
Endovia Health Sciences debt-to-ebitda ratio trends
Over the last five fiscal years, Endovia Health Sciences's debt-to-ebitda ratio decreased from 8.43 to 0.17, a change of −8.26. The latest reported quarter, Q4 2018, shows 0.17.
What the debt-to-EBITDA ratio means
Debt-to-EBITDA compares interest-bearing debt with operating earnings before interest, taxes, depreciation, and amortization. It is commonly used to assess leverage, but it is generally unsuitable for banks and other financial companies.
How debt-to-EBITDA is calculated
TickerStat divides period-end total debt by annual EBITDA. Quarterly observations use trailing-12-month EBITDA. Periods with zero or negative EBITDA are excluded because the leverage multiple would not be meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Endovia Health Sciences source filings ↗